1. Hendrickson MR, Tavassoli F, Kempson RL, McCluggage G, Hailer U, Kubik-Huch RA (2003) Mesenchymal tumours and related lesions. In: Tavassoli FA, Deville P (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female organs. IARC Press, Lyon, France, pp 233–244
2. Kurman RJ, Carcangiu ML, Herrington CS, Young R (2014) WHO Classification of tumours of female reproductive organs. 4th Edition, Volume 6. IARC Press, Lyon, France: 135–50
3. Parra-Herran C, Howitt BE (2019) Uterine mesenchymal tumors: update on classification, staging, and molecular features. Surg Pathol Clin 12(2):363–396. https://doi.org/10.1016/j.path.2019.01.004
4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Uterine Neoplasms, Version 1.2020. https://www.nccn.org. Accessed 29 May 2020
5. Tanner EJ, Garg K, Leitao MM Jr, Soslow RA, Hensley ML (2012) High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol Oncol 127(1):27–31. https://doi.org/10.1016/j.ygyno.2012.06.030